Biotechnology
Compare Stocks
5 / 10Stock Comparison
MLEC vs SMPL vs BYND vs NOMD vs HAIN
Revenue, margins, valuation, and 5-year total return — side by side.
Packaged Foods
Packaged Foods
Packaged Foods
Packaged Foods
MLEC vs SMPL vs BYND vs NOMD vs HAIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Biotechnology | Packaged Foods | Packaged Foods | Packaged Foods | Packaged Foods |
| Market Cap | $7M | $1.24B | $414M | $1.44B | $84M |
| Revenue (TTM) | $8M | $1.45B | $265M | $3.03B | $1.51B |
| Net Income (TTM) | $-8M | $91M | $244M | $137M | $-544M |
| Gross Margin | -8.2% | 34.0% | 3.5% | 27.1% | 20.0% |
| Operating Margin | -116.7% | 14.4% | -82.4% | 10.7% | -31.8% |
| Forward P/E | — | 7.4x | — | 6.2x | — |
| Total Debt | $247M | $304M | $508M | $2.29B | $779M |
| Cash & Equiv. | $768K | $98M | $208M | $325M | $54M |
MLEC vs SMPL vs BYND vs NOMD vs HAIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Moolec Science S.A. (MLEC) | 100 | 91.8 | -8.2% |
| The Simply Good Foo… (SMPL) | 100 | 40.3 | -59.7% |
| Beyond Meat, Inc. (BYND) | 100 | 0.6 | -99.4% |
| Nomad Foods Limited (NOMD) | 100 | 34.4 | -65.6% |
| The Hain Celestial … (HAIN) | 100 | 1.5 | -98.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MLEC vs SMPL vs BYND vs NOMD vs HAIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MLEC is the #2 pick in this set and the best alternative if growth and momentum is your priority.
- 58.3% revenue growth vs BYND's -15.6%
- -2.0% vs BYND's -64.9%
SMPL is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 9.0%, EPS growth -26.1%, 3Y rev CAGR 7.5%
- Lower volatility, beta 0.38, Low D/E 16.8%, current ratio 3.64x
- Beta 0.38, current ratio 3.64x
BYND ranks third and is worth considering specifically for quality and efficiency.
- 92.2% margin vs MLEC's -105.7%
- 39.3% ROA vs HAIN's -36.8%, ROIC -44.4% vs -23.7%
NOMD carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.07, yield 7.1%
- 40.1% 10Y total return vs MLEC's -8.5%
- Better valuation composite
- Beta 0.07 vs HAIN's 2.12, lower leverage
Among these 5 stocks, HAIN doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 58.3% revenue growth vs BYND's -15.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 92.2% margin vs MLEC's -105.7% | |
| Stability / Safety | Beta 0.07 vs HAIN's 2.12, lower leverage | |
| Dividends | 7.1% yield; 2-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | -2.0% vs BYND's -64.9% | |
| Efficiency (ROA) | 39.3% ROA vs HAIN's -36.8%, ROIC -44.4% vs -23.7% |
MLEC vs SMPL vs BYND vs NOMD vs HAIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
MLEC vs SMPL vs BYND vs NOMD vs HAIN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SMPL leads in 2 of 6 categories
NOMD leads 2 • MLEC leads 0 • BYND leads 0 • HAIN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SMPL leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NOMD is the larger business by revenue, generating $3.0B annually — 387.1x MLEC's $8M. BYND is the more profitable business, keeping 92.2% of every revenue dollar as net income compared to MLEC's -105.7%. On growth, MLEC holds the edge at +9.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $8M | $1.4B | $265M | $3.0B | $1.5B |
| EBITDAEarnings before interest/tax | -$8M | $231M | -$187M | $435M | -$430M |
| Net IncomeAfter-tax profit | -$8M | $91M | $244M | $137M | -$544M |
| Free Cash FlowCash after capex | -$6M | $174M | -$134M | $252M | $5M |
| Gross MarginGross profit ÷ Revenue | -8.2% | +34.0% | +3.5% | +27.1% | +20.0% |
| Operating MarginEBIT ÷ Revenue | -116.7% | +14.4% | -82.4% | +10.7% | -31.8% |
| Net MarginNet income ÷ Revenue | -105.7% | +6.3% | +92.2% | +4.5% | -36.1% |
| FCF MarginFCF ÷ Revenue | -78.1% | +12.0% | -50.6% | +8.3% | +0.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.5% | -0.3% | -15.3% | -2.6% | -6.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -20.0% | -31.6% | +90.9% | -123.1% | -11.3% |
Valuation Metrics
NOMD leads this category, winning 2 of 6 comparable metrics.
Valuation Metrics
At 9.5x trailing earnings, NOMD trades at a 22% valuation discount to SMPL's 12.2x P/E. On an enterprise value basis, SMPL's 6.0x EV/EBITDA is more attractive than MLEC's 21.5x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $7M | $1.2B | $414M | $1.4B | $84M |
| Enterprise ValueMkt cap + debt − cash | $253M | $1.4B | $714M | $3.7B | $808M |
| Trailing P/EPrice ÷ TTM EPS | -0.03x | 12.20x | -0.49x | 9.46x | -0.13x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 7.39x | — | 6.23x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 0.51x | — | — | — |
| EV / EBITDAEnterprise value multiple | 21.45x | 5.97x | — | 7.34x | — |
| Price / SalesMarket cap ÷ Revenue | 0.02x | 0.86x | 1.50x | 0.40x | 0.05x |
| Price / BookPrice ÷ Book value/share | — | 0.70x | — | 0.52x | 0.14x |
| Price / FCFMarket cap ÷ FCF | — | 7.86x | — | 4.85x | — |
Profitability & Efficiency
SMPL leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
NOMD delivers a 5.3% return on equity — every $100 of shareholder capital generates $5 in annual profit, vs $-165 for HAIN. SMPL carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to HAIN's 1.64x. On the Piotroski fundamental quality scale (0–9), SMPL scores 5/9 vs HAIN's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -150.9% | +5.2% | — | +5.3% | -164.7% |
| ROA (TTM)Return on assets | -26.6% | +3.7% | +39.3% | +2.2% | -36.8% |
| ROICReturn on invested capital | -8.8% | +8.1% | -44.4% | +5.5% | -23.7% |
| ROCEReturn on capital employed | — | +9.4% | -40.3% | +6.2% | -29.2% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 3 | 4 | 3 |
| Debt / EquityFinancial leverage | — | 0.17x | — | 0.92x | 1.64x |
| Net DebtTotal debt minus cash | $246M | $206M | $300M | $2.0B | $725M |
| Cash & Equiv.Liquid assets | $767,919 | $98M | $208M | $325M | $54M |
| Total DebtShort + long-term debt | $247M | $304M | $508M | $2.3B | $779M |
| Interest CoverageEBIT ÷ Interest expense | -2.94x | 6.77x | -11.47x | 2.52x | -8.60x |
Total Returns (Dividends Reinvested)
Evenly matched — MLEC and NOMD each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MLEC five years ago would be worth $9,201 today (with dividends reinvested), compared to $81 for BYND. Over the past 12 months, MLEC leads with a -2.0% total return vs BYND's -64.9%. The 3-year compound annual growth rate (CAGR) favors NOMD at -15.8% vs HAIN's -65.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3153.6% | -36.4% | +1.3% | -15.4% | -29.8% |
| 1-Year ReturnPast 12 months | -2.0% | -64.8% | -64.9% | -43.5% | -49.2% |
| 3-Year ReturnCumulative with dividends | -70.1% | -67.8% | -93.1% | -40.3% | -95.8% |
| 5-Year ReturnCumulative with dividends | -8.0% | -64.3% | -99.2% | -59.7% | -98.2% |
| 10-Year ReturnCumulative with dividends | -8.5% | +3.7% | -98.6% | +40.1% | -98.5% |
| CAGR (3Y)Annualised 3-year return | -33.1% | -31.5% | -59.1% | -15.8% | -65.3% |
Risk & Volatility
NOMD leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NOMD is the less volatile stock with a 0.07 beta — it tends to amplify market swings less than HAIN's 2.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NOMD currently trades 51.3% from its 52-week high vs BYND's 11.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.76x | 0.34x | 1.82x | 0.08x | 2.19x |
| 52-Week HighHighest price in past year | $23.22 | $36.92 | $7.69 | $19.71 | $2.22 |
| 52-Week LowLowest price in past year | $0.20 | $10.21 | $0.50 | $9.17 | $0.55 |
| % of 52W HighCurrent price vs 52-week peak | +38.7% | +33.7% | +11.6% | +51.3% | +33.2% |
| RSI (14)Momentum oscillator 0–100 | 51.3 | 42.9 | 60.7 | 58.6 | 47.8 |
| Avg Volume (50D)Average daily shares traded | 319K | 2.8M | 59.5M | 1.6M | 1.2M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: SMPL as "Buy", BYND as "Sell", NOMD as "Buy", HAIN as "Hold". Consensus price targets imply 4889.9% upside for BYND (target: $45) vs 33.4% for NOMD (target: $14). NOMD is the only dividend payer here at 7.06% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Sell | Buy | Hold |
| Price TargetConsensus 12-month target | — | $18.33 | $44.55 | $13.50 | $1.17 |
| # AnalystsCovering analysts | — | 24 | 21 | 13 | 44 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +7.1% | — |
| Dividend StreakConsecutive years of raises | — | — | — | 2 | — |
| Dividend / ShareAnnual DPS | — | — | — | $0.61 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +14.2% | +4.1% | 0.0% | +16.5% | +1.7% |
SMPL leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NOMD leads in 2 (Valuation Metrics, Risk & Volatility). 1 tied.
MLEC vs SMPL vs BYND vs NOMD vs HAIN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MLEC or SMPL or BYND or NOMD or HAIN a better buy right now?
For growth investors, Moolec Science S.
A. (MLEC) is the stronger pick with 58. 3% revenue growth year-over-year, versus -15. 6% for Beyond Meat, Inc. (BYND). Nomad Foods Limited (NOMD) offers the better valuation at 9. 5x trailing P/E (6. 2x forward), making it the more compelling value choice. Analysts rate The Simply Good Foods Company (SMPL) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MLEC or SMPL or BYND or NOMD or HAIN?
On trailing P/E, Nomad Foods Limited (NOMD) is the cheapest at 9.
5x versus The Simply Good Foods Company at 12. 2x. On forward P/E, Nomad Foods Limited is actually cheaper at 6. 2x.
03Which is the better long-term investment — MLEC or SMPL or BYND or NOMD or HAIN?
Over the past 5 years, Moolec Science S.
A. (MLEC) delivered a total return of -8. 0%, compared to -99. 2% for Beyond Meat, Inc. (BYND). Over 10 years, the gap is even starker: NOMD returned +31. 8% versus BYND's -98. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MLEC or SMPL or BYND or NOMD or HAIN?
By beta (market sensitivity over 5 years), Nomad Foods Limited (NOMD) is the lower-risk stock at 0.
08β versus The Hain Celestial Group, Inc. 's 2. 19β — meaning HAIN is approximately 2766% more volatile than NOMD relative to the S&P 500. On balance sheet safety, The Simply Good Foods Company (SMPL) carries a lower debt/equity ratio of 17% versus 164% for The Hain Celestial Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MLEC or SMPL or BYND or NOMD or HAIN?
By revenue growth (latest reported year), Moolec Science S.
A. (MLEC) is pulling ahead at 58. 3% versus -15. 6% for Beyond Meat, Inc. (BYND). On earnings-per-share growth, the picture is similar: Beyond Meat, Inc. grew EPS 24. 7% year-over-year, compared to -89. 8% for Moolec Science S. A.. Over a 3-year CAGR, SMPL leads at 7. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MLEC or SMPL or BYND or NOMD or HAIN?
Beyond Meat, Inc.
(BYND) is the more profitable company, earning 79. 8% net margin versus -34. 0% for The Hain Celestial Group, Inc. — meaning it keeps 79. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMPL leads at 15. 1% versus -84. 7% for BYND. At the gross margin level — before operating expenses — SMPL leads at 35. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MLEC or SMPL or BYND or NOMD or HAIN more undervalued right now?
On forward earnings alone, Nomad Foods Limited (NOMD) trades at 6.
2x forward P/E versus 7. 4x for The Simply Good Foods Company — 1. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BYND: 4889. 9% to $44. 55.
08Which pays a better dividend — MLEC or SMPL or BYND or NOMD or HAIN?
In this comparison, NOMD (7.
1% yield) pays a dividend. MLEC, SMPL, BYND, HAIN do not pay a meaningful dividend and should not be held primarily for income.
09Is MLEC or SMPL or BYND or NOMD or HAIN better for a retirement portfolio?
For long-horizon retirement investors, Nomad Foods Limited (NOMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
08), 7. 1% yield). The Hain Celestial Group, Inc. (HAIN) carries a higher beta of 2. 19 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NOMD: +31. 8%, HAIN: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MLEC and SMPL and BYND and NOMD and HAIN?
These companies operate in different sectors (MLEC (Healthcare) and SMPL (Consumer Defensive) and BYND (Consumer Defensive) and NOMD (Consumer Defensive) and HAIN (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MLEC is a small-cap high-growth stock; SMPL is a small-cap deep-value stock; BYND is a small-cap quality compounder stock; NOMD is a small-cap deep-value stock; HAIN is a small-cap quality compounder stock. NOMD pays a dividend while MLEC, SMPL, BYND, HAIN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.